Apnimed, Inc. APMD 深 沪
已收盘 08-14 16:00:00 美东时间
31.75
+2.960
+10.28%
华盛通- 最 高33.095
- 今 开30.61
- 成交量 65.09万股
- 最 低 28.06
- 昨 收 28.79
- 总市值 120.65万
- 52周最高 33.095
- 市盈率 静 --
- 换手率 1713.03%
- 52周最低 16.12
- 委 比 -99.13%
- 总股本 3.80万
- 历史最高 33.095
- 量 比 1.87
- 振 幅 17.49%
- 历史最低 16.12
- 每 手 1
- 风险率 3.28%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多AstraZeneca, GameStop, Snap And Other Big Stocks Moving Lower In Monday’s Pre-Market Session
U.S. stock futures were higher this morning, with the Dow futures gaining around 400 points on Monday. Shares of AstraZeneca PLC (NYSE:AZN) dipped 6% to $159.54 in pre-market trading. AstraZeneca is reportedly in discussions with Bristol Myers Squibb (NYSE:BMY) to merge, potentially forming a pharma...
08-03 20:01
Apnimed Announces Pricing of Upsized Initial Public Offering
CAMBRIDGE, Mass., July 30, 2026 /PRNewswire/ -- Apnimed, Inc. ("Apnimed"), a late stage clinical pharmaceutical company dedicated to the discovery, development, and commercialization of nove...
07-31 10:10
Braveheart Bio, Attovia seek $275M and $182M in U.S. IPOs
Clinical-stage biopharma companies Braveheart Bio (BRVE) and Attovia Therapeutics (ATTO) have announced plans to raise $274.5M and $182.4M in net proceeds, respectively, from their initial public offe...
07-30 23:57
